Genotoxicity of 2-(3-chlorobenzyloxy)-6-(piperazinyl)pyrazine, a novel 5-hydroxytryptamine2c receptor agonist for the treatment of obesity: role of metabolic activation. (Q50073282)
Jump to navigation
Jump to search
scientific article published on 7 March 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Genotoxicity of 2-(3-chlorobenzyloxy)-6-(piperazinyl)pyrazine, a novel 5-hydroxytryptamine2c receptor agonist for the treatment of obesity: role of metabolic activation. |
scientific article published on 7 March 2007 |
Statements
1 reference
Genotoxicity of 2-(3-chlorobenzyloxy)-6-(piperazinyl)pyrazine, a novel 5-hydroxytryptamine2c receptor agonist for the treatment of obesity: role of metabolic activation. (English)
1 reference
Amit S Kalgutkar
1 reference
Deepak K Dalvie
1 reference
Jiri Aubrecht
1 reference
Evan B Smith
1 reference
Stephanie L Coffing
1 reference
Jennifer R Cheung
1 reference
Chandra Vage
1 reference
Mary E Lame
1 reference
Phoebe Chiang
1 reference
Kim F McClure
1 reference
Tristan S Maurer
1 reference
Richard V Coelho
1 reference
Victor F Soliman
1 reference
Klaas Schildknegt
1 reference
7 March 2007
1 reference
1 reference
35
1 reference
6
1 reference
848-858
1 reference
Identifiers
1 reference
1 reference